Pediatric HIV drug gains FDA approval

05/6/2013 | Drug Store News

Bristol-Myers Squibb received federal approval of its Sustiva drug for children with HIV as young as 3 months. The approval allows the capsule to be opened and added to food or a beverage for patients who cannot swallow capsules or tablets.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY